Compounds > canrenoic acid
Page last updated: 2024-08-16

canrenoic acid and isoproterenol

canrenoic acid has been researched along with isoproterenol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eandi, M; Miocchi, D; Ricci Gamalero, S1
Bos, R; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM1
Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM1

Other Studies

3 other study(ies) available for canrenoic acid and isoproterenol

ArticleYear
Response to nor-epinephrine, isoprenaline and spironolactone derivatives in normal and hypertensive rats.
    Bollettino della Societa italiana di biologia sperimentale, 1979, Jul-15, Volume: 55, Issue:13

    Topics: Animals; Blood Pressure; Canrenoic Acid; Heart Rate; Hypertension, Renal; Isoproterenol; Norepinephrine; Rats; Spironolactone; Time Factors

1979
Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3

    Topics: Animals; Blood Pressure; Canrenoic Acid; Cardiomyopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Isoproterenol; Male; Mineralocorticoid Receptor Antagonists; Neurotransmitter Agents; Rats; Rats, Wistar

2004
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
    Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:1

    Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Canrenoic Acid; Fibrosis; Heart Failure; Isoproterenol; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta

2005